Pharmaceuticals Native Starch Market Report 2026

Pharmaceuticals Native Starch Market Overview

• Pharmaceuticals Native Starch market size has reached to $6.11 billion in 2025 • Expected to grow to $9.23 billion in 2030 at a compound annual growth rate (CAGR) of 8.6% • Growth Driver: Increasing Prevalence Of Chronic Diseases Fuel Market Growth Due To Aging Populations Unhealthy Lifestyles And Environmental Factors • Market Trend: Revolutionary Technological Advancements In The Evolution Of Starch Solutions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pharmaceuticals Native Starch Market?

Pharmaceutical native starch is unaltered starch derived from natural sources such as corn, potato, wheat, or tapioca and utilized as an excipient in pharmaceutical formulations. It functions as a binder, disintegrant, or filler in tablets and capsules, helping to control medication release, increase stability, and maintain appropriate tablet formation without requiring chemical or physical change. The main types of pharmaceutical native starches are potato starch, corn starch, and others. Potato starch, a fine, white powder derived from potato tubers, is known for its smooth texture and excellent binding properties, making it ideal for tablet formulations in pharmaceuticals. It is available in multiple formulation types, including oral solid dosage forms, liquid dosage forms, topical formulations, injectable drugs, and controlled-release formulations, for its functionality encompasses roles such as a texturizing agent, moisture retention agent, bulking agent, emulsifying agent, and film-forming agent. It is applied in various uses, including binders and coating agents, disintegrants, fillers and extenders, stabilizers, and thickening agents, catering to end-users, including pharmaceutical manufacturers, contract research organizations (CROs), contract manufacturing organizations (CMOs), research and development laboratories, academic institutions, and others.

What Is The Pharmaceuticals Native Starch Market Growth Forecast?

The pharmaceuticals native starch market size is expected to see strong growth in the next few years. It will grow to $9.23 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to growth in clean-label drug formulations, increasing sustainability requirements, expansion of pharmaceutical manufacturing in emerging markets, rising demand for biodegradable excipients, advancements in starch processing. Major trends in the forecast period include growing demand for natural and clean-label excipients, increasing use in solid oral dosage forms, rising adoption as binder and disintegrant, expansion of plant-based pharmaceutical ingredients, increasing focus on cost-effective excipients.

Global Pharmaceuticals Native Starch Market Segmentation

1) By Type: Potato Starch, Corn Starch, Other Types 2) By Formulation Type: Oral Solid Dosage Forms, Liquid Dosage Forms, Topical Formulations, Injectable Drugs, Controlled Release Formulations 3) By Functionality: Texturizing Agent, Moisture Retention Agent, Bulking Agent, Emulsifying Agent, Film-Forming Agent 4) By Application: Binders And Coating Agents, Disintegrants, Fillers And Extenders, Stabilizers, Thickening Agents 5) By End-User: Pharmaceutical Manufacturers, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), Research And Development Labs, Academic Institutions, Other End-users Subsegments: 1) By Potato Starch: Native Potato Starch (Pharmaceutical Grade), Low Moisture Native Potato Starch, Fine Particle Size Native Potato Starch, High Purity Native Potato Starch 2) By Corn Starch: Native Corn Starch (Pharmaceutical Grade), Low Moisture Native Corn Starch, Fine Particle Size Native Corn Starch, High Purity Native Corn Starch 3) By Other Types: Rice Starch, Wheat Starch, Tapioca Starch

What Are The Drivers Of The Pharmaceuticals Native Starch Market?

The increasing prevalence of chronic diseases is expected to propel the growth of the pharmaceuticals native starch market going forward. Chronic diseases are long-lasting medical conditions that typically progress slowly and persist for a year or more. The increasing prevalence of chronic diseases is primarily attributed to the rising aging population, as older individuals are more susceptible to long-term health conditions such as diabetes, cardiovascular diseases, arthritis, and cancer, which tend to become more common with age. Pharmaceuticals native starch is helpful for chronic diseases by improving drug formulation stability, enhancing bioavailability, enabling controlled drug release, supporting patient compliance, and ultimately strengthening the effectiveness and long-term management of chronic medical conditions. For instance, in April 2025, according to the Centers for Disease Control and Prevention, a US-based federal public health agency, 76.4% of U.S. adults representing about 194 million people reported having one or more chronic conditions in 2023, with prevalence at 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Therefore, the increasing prevalence of chronic diseases is driving the growth of the pharmaceuticals native starch industry. The expansion of generic drug manufacturing is expected to propel the growth of the pharmaceuticals native starch market going forward. Generic drug manufacturing refers to the production of off patent medications that are bioequivalent to branded drugs. Generic drug manufacturing is rising due to increasing regulatory support that speeds up approvals and encourages more companies to produce affordable alternatives to branded medicines. Expansion of generic drug manufacturing is supporting pharmaceuticals native starch by increasing the need for reliable, cost-effective excipients that enhance tablet formulation, stability, and drug delivery efficiency across a broader range of high-volume generic medicines. For instance, in November 2024, according to the Food and Drug Administration (FDA), a US-based federal agency, in FY 2023, the FDA approved 782 Abbreviated New Drug Applications (ANDAs), an increase from 722 approvals recorded in FY 2022. Therefore, the expansion of generic drug manufacturing is driving the growth of the pharmaceuticals native starch industry.

Key Players In The Global Pharmaceuticals Native Starch Market

Major companies operating in the pharmaceuticals native starch market are Cargill Incorporated, Archer Daniels Midland Company, Ingredion Incorporated, Roquette Frères SA, Emsland Group, Tereos SCA, AGRANA Beteiligungs-AG, Grain Processing Corporation, Universal Starch-Chem Allied Ltd., SPAC Starch Products (India) Private Limited, Sanstar Biopolymers Ltd., Gulshan Polyols Ltd., Tate & Lyle Public Limited Company, BENEO GmbH, Hungrana Kft., Bluecraft Agro Pvt. Ltd., Visco Starch, Manildra Group, Shandong Liujia Pharmaceutical Excipient Co. Ltd., Zhucheng Xingmao Corn Developing Co. Ltd.

Global Pharmaceuticals Native Starch Market Trends and Insights

Major companies operating in the pharmaceuticals native starch market are focusing on developing innovative products, such as plant-based textures, to enhance drug formulation and improve patient compliance. Plant-based texture refers to the physical properties derived from plant ingredients, such as thickness and gel strength, and helps pharmaceuticals use native starch by enhancing tablet binding, disintegration, and mouthfeel for improved natural drug formulations. For instance, in February 2024, Ingredion Incorporated, a US-based food company, launched Novation Indulge 2940 starch, a clean-label texturizer designed to enhance texture and stability in dairy and alternative dairy products. This innovative pharmaceutical native starch offers functional properties that enhance drug formulation performance, bioavailability, and controlled release while supporting the development of clean-label, sustainable products. NOVATION Indulge 2940 starch is a versatile ingredient that improves texture, stability, and consumer acceptance in both dairy and alternative dairy products, using clean-label, natural ingredients.

Regional Insights

North America was the largest region in the pharmaceuticals native starch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pharmaceuticals Native Starch Market?

The pharmaceuticals native starch market consists of sales of sorghum starch, barley starch, sweet potato starch, and arrowroot starch. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pharmaceuticals Native Starch Market Report 2026?

The pharmaceuticals native starch market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceuticals native starch industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.